Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

Share Price is delayed by 15 minutes
Get Live Data
303.50    0.00 (0.00%)
Bid:
303.50
Ask:
304.00
Spread: 0.50 (0.165%)
Market Cap: £179.17m
TET Live PriceLast checked at - London Stock Exchange

Intraday Treatt Share Chart

Form 8.3 TREATT PLC

26 Sep 2025 14:28

RNS Number : 0645B
Barclays PLC
26 September 2025
Β 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Β 

Barclays PLC.

(b)

Owner or controller of interest and short

Β 

Β 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

TREATT PLC

Β 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

Β 

Β 

offeror/offeree, state this and specify identity of

Β 

offeror/offeree:

(e)

Date position held/dealing undertaken:

25 Sep 2025

(f)

In addition to the company in 1(c) above, is the discloser making

NO

Β 

Β 

Β 

disclosures in respect of any other party to the offer?

Β 

Β 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

Β 

Β 

to which the disclosure relates following the dealing(if any)

Β 

Class of relevant security:

2p ordinary

Β 

Interests

Short Positions

Β 

Number

(%)

Number

(%)

(1)

Relevant securities owned

Β 

Β 

Β 

Β 

Β 

and/or controlled:

Β 

Β 

469,228

0.80%

315,839

0.54%

(2)

Cash-settled derivatives:

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

196,769

0.33%

414,981

0.70%

(3)

Stock-settled derivatives (including options)

Β 

Β 

Β 

Β 

Β 

and agreements to purchase/sell:

Β 

Β 

0

0.00%

0

0.00%

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

TOTAL:

Β 

Β 

665,997

1.13%

730,820

1.24%

(b)

Rights to subscribe for new securities (including directors and other executive

Β 

Β 

options)

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant security in relation to

Β 

Β 

Β 

Β 

which subscription right exists

Β 

Β 

Β 

Β 

Details, including nature of the rights

Β 

Β 

Β 

Β 

concerned and relevant percentages:

Β 

Β 

Β 

Β 

3.

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a)

Purchases and sales

Β 

Β 

Β 

Β 

Β 

Class of relevant

Purchase/sale

Number of

Price per unit

security

Β 

securities

Β 

2p ordinary

Purchase

5,707

2.6800 GBP

2p ordinary

Purchase

4,192

2.6749 GBP

2p ordinary

Purchase

3,000

2.6795 GBP

2p ordinary

Purchase

2,420

2.6763 GBP

2p ordinary

Purchase

1,418

2.6772 GBP

2p ordinary

Purchase

632

2.6877 GBP

2p ordinary

Purchase

198

2.6784 GBP

2p ordinary

Purchase

182

2.6715 GBP

2p ordinary

Purchase

99

2.6758 GBP

2p ordinary

Sale

11,609

2.6750 GBP

2p ordinary

Sale

6,343

2.6800 GBP

2p ordinary

Sale

1,650

2.6835 GBP

2p ordinary

Sale

705

2.6774 GBP

2p ordinary

Sale

517

2.6799 GBP

2p ordinary

Sale

373

2.6730 GBP

2p ordinary

Sale

132

2.6925 GBP

2p ordinary

Sale

47

2.6725 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(b)

Cash-settled derivative transactions

Β 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

Β 

reference

unit

security

Β 

Β 

securities

Β 

2p ordinary

SWAP

Decreasing Short

307

2.6776 GBP

2p ordinary

SWAP

Decreasing Short

81

2.6784 GBP

2p ordinary

SWAP

Decreasing Short

51

2.6785 GBP

2p ordinary

SWAP

Decreasing Short

517

2.6799 GBP

2p ordinary

SWAP

Decreasing Short

41

2.6800 GBP

2p ordinary

SWAP

Decreasing Short

332

2.6808 GBP

2p ordinary

SWAP

Increasing Short

754

2.6800 GBP

2p ordinary

CFD

Decreasing Short

200

2.6699 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(c)

Stock-settled derivative transactions (including options)

Β 

(i)

Writing, selling, purchasing or varying

Β 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

Β 

date

money

relevant

Β 

selling,

securities

per unit

Β 

Β 

paid/

security

Β 

varying etc

to which

Β 

Β 

Β 

received

Β 

Β 

Β 

option

Β 

Β 

Β 

per unit

Β 

Β 

Β 

relates

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(ii)

Exercise

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

Β 

Β 

securities

unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(d)

Other dealings (including subscribing for new securities)

Β 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

Β 

Β 

applicable)

Β 

Β 

Β 

Β 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding,

Β 

Β 

formal or informal, relating to relevant securities which may be an inducement to deal

Β 

Β 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

Β 

to the offer or any person acting in concert with a party to the offer:

Β 

Β 

Β 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between

Β 

Β 

the person making the disclosure and any other person relating to:

Β 

Β 

(i) the voting rights of any relevant securities under any option; or

Β 

Β 

Β 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

Β 

Β 

any derivative is referenced:

Β 

Β 

Β 

Β 

Β 

Β 

NONE

(c)

Attachments

Β 

Β 

Β 

Β 

Β 

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

26 Sep 2025

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETUNUORVBUKUAR
Date   Source Headline
17th Jun 20263:25 pmRNSForm 8.3 - Treatt plc
17th Jun 202612:35 pmRNSForm 8.3 TREATT PLC
17th Jun 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
17th Jun 202611:21 amRNS20260616_TREATT PLC_8.5 EPT RI_UK_MLI
17th Jun 202610:32 amRNSForm 8.3 Treatt plc
17th Jun 202610:15 amBUSForm 8.5 (EPT/RI)-Treatt Plc
16th Jun 202612:55 pmRNSForm 8.3 TREATT PLC
16th Jun 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
16th Jun 20269:30 amBUSForm 8.5 (EPT/RI)-Treatt Plc
16th Jun 20267:00 amRNSUpdate on Regulatory Conditions & Scheme Timetable
15th Jun 20262:10 pmRNSForm 8.3 TREATT PLC
15th Jun 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
15th Jun 202611:26 amRNSForm 8.3 Treatt Plc
15th Jun 202611:12 amRNS20260612_TREATT PLC_8.5 EPT RI_UK_MLI
15th Jun 202610:02 amBUSForm 8.5 (EPT/RI)-Treatt Plc
12th Jun 20261:09 pmRNSForm 8.3 TREATT PLC
12th Jun 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
12th Jun 202610:39 amBUSForm 8.5 (EPT/RI)-Treatt Plc
12th Jun 202610:34 amRNSForm 8.3 Treatt plc
11th Jun 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
11th Jun 202611:28 amRNSForm 8.3 TREATT PLC
11th Jun 202610:55 amBUSForm 8.5 (EPT/RI)-Treatt Plc
10th Jun 20262:02 pmRNSForm 8.3 TREATT PLC
10th Jun 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
10th Jun 202611:47 amRNS20260609_TREATT PLC_8.5 EPT RI_UK_MLI
10th Jun 202610:20 amRNSForm 8.3 Treatt plc
9th Jun 20263:25 pmRNSForm 8.3 - Treatt plc
9th Jun 20262:55 pmRNSResults of the Court Meeting and General Meeting
9th Jun 202612:40 pmRNSForm 8.3 TREATT PLC
9th Jun 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
9th Jun 202610:39 amRNSForm 8.3 Treatt Plc
8th Jun 20263:25 pmRNSForm 8.3 - Treatt plc
8th Jun 20261:50 pmRNSForm 8.3 TREATT PLC
8th Jun 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
8th Jun 202610:05 amRNSForm 8.3 Treatt plc
5th Jun 20263:25 pmRNSForm 8.3 - Treatt plc
5th Jun 20261:23 pmRNSForm 8.3 - Treatt plc
5th Jun 202612:57 pmRNSForm 8.3 TREATT PLC
5th Jun 202610:02 amRNSForm 8.3 Treatt Plc
4th Jun 20264:37 pmRNSHolding(s) in Company
4th Jun 20261:54 pmRNSForm 8.3 TREATT PLC
4th Jun 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
4th Jun 202610:26 amRNSForm 8.3 Treatt plc
3rd Jun 20263:12 pmRNSForm 8.3 TREATT PLC
3rd Jun 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
3rd Jun 202611:12 amRNSForm 8.3 Treatt Plc
3rd Jun 20267:00 amRNSHolding(s) in Company
2nd Jun 20262:59 pmRNSForm 8.3 TREATT PLC
2nd Jun 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
2nd Jun 202611:52 amRNSForm 8.3 Treatt plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.